We recently published a list of 10 AI News and Ratings Investors Should Take a Look At. In this article, we are going to take a look at where Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) stands against other AI news and ratings investors should take a look at.
As AI continues to reshape industries, investors are closely watching how companies allocate capital during concerns over high valuations. According to some experts, despite market fluctuations, businesses are unlikely to cut AI investments significantly, as the technology’s long-term impact is still unfolding. The comparison to the dot-com era raises questions about sustainability, but many see AI as an innovation cycle that will drive broader economic growth.
Balancing AI Growth with Market Valuation Concerns
Marta Norton, chief investment strategist at Empower, believes companies are unlikely to significantly alter their AI-related spending despite concerns over high valuations, especially as DeepSeek raises questions about supply chains. She discussed this on Bloomberg Technology with Caroline Hyde and Mike Shepard, emphasizing that the market is still in an AI investment race and earnings reports will be key in determining future spending patterns.
She noted that recent market reactions have been more about valuation concerns than doubts about AI itself. While Nvidia remains central to AI supply chains, the debate is now shifting to whether businesses need to keep spending at the current pace. Comparing the situation to the dot-com era, Norton acknowledged the risks of high valuations but pointed out that major technological shifts, like AI, can drive long-term economic expansion, similar to how the internet transformed industries.
On the potential impact of cheaper AI solutions, she suggested that businesses, including retailers and software firms, could benefit from faster, more efficient deployments. However, she cautioned that these effects may take time to materialize rather than being immediately reflected in quarterly earnings. Addressing concerns about broader market disruption, she acknowledged vulnerabilities in major tech stocks but argued that the fundamental case for AI remains strong, with the primary uncertainty revolving around supply chains rather than AI adoption itself.
For this article, we selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A biotechnology worker carefully inspecting a vial of cell samples through a microscope.
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)
Number of Hedge Fund Holders: 4
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) develops innovative cell therapies for cancer, autoimmune, and infectious diseases, with a focus on advanced immunotherapies and partnerships for treatment development.
On January 30, Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) rebranded to COEPTIS, marking a shift in its business strategy to include technology-driven sectors. The company has launched a new Technology Division, which recently acquired the NexGenAI Affiliates Network platform, an AI-powered marketing solution. This acquisition is part of COEPTIS’s effort to revolutionize marketing strategies and improve operational efficiency in regulated industries. With a focus on AI-driven precision, automation, and intelligent workflow optimization, COEPTIS aims to create sustainable, revenue-generating units to position itself for long-term growth and profitability.
Overall, COEP ranks 8th on our list of AI news and ratings investors should take a look at. While we acknowledge the potential of COEP as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than COEP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article is originally published at Insider Monkey.
